Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Cantor Fitzgerald
Cipla
Moodys
Farmers Insurance
Colorcon
Merck
Teva
Boehringer Ingelheim
Argus Health
Harvard Business School

Generated: December 11, 2017

DrugPatentWatch Database Preview

Patents Expiring in March 2018

« Back to Dashboard

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Patent Submitted Product Substance Delist Req. Patented / Exclusive Use
J And J Consumer IncPEPCID COMPLETEcalcium carbonate; famotidine; magnesium hydroxideTABLET, CHEWABLE;ORAL020958-001Oct 16, 2000OTCYesYes► Subscribe► Subscribe► SubscribeY
Pf Prism CvBOSULIFbosutinib monohydrateTABLET;ORAL203341-001Sep 4, 2012RXYesYes► Subscribe► Subscribe► SubscribeYYA METHOD OF TREATING A NEOPLASM
Pf Prism CvBOSULIFbosutinib monohydrateTABLET;ORAL203341-003Oct 27, 2017RXYesNo► Subscribe► Subscribe► SubscribeYYA METHOD OF TREATING A NEOPLASM
Pf Prism CvBOSULIFbosutinib monohydrateTABLET;ORAL203341-002Sep 4, 2012RXYesNo► Subscribe► Subscribe► SubscribeYYA METHOD OF TREATING A NEOPLASM
TaroTOPICORTdesoximetasoneSPRAY;TOPICAL204141-001Apr 11, 2013ATRXYesYes► Subscribe► Subscribe► SubscribeYTREATMENT OF PLAQUE PSORIASIS IN PATIENTS 18 YEARS OF AGE OR OLDER
Galderma Labs LpCLOBEXclobetasol propionateSPRAY;TOPICAL021835-001Oct 27, 2005ATRXYesYes► Subscribe► Subscribe► SubscribeYTWICE DAILY TOPICAL TREATMENT OF MODERATE TO SEVERE PLAQUE PSORIASIS.
Covis Pharma BvALTOPREVlovastatinTABLET, EXTENDED RELEASE;ORAL021316-001Jun 26, 2002DISCNNoNo► Subscribe► Subscribe► SubscribeMETHOD OF DECREASING THE PRODUCTION OF A-BETA USING A COMPOSITION WHICH DECREASES BLOOD CHOLESTEROL IN PATIENTS AT RISK OF OR EXHIBITING SYMPTOMS OF ALZHEIMER'S DISEASE
Covis Pharma BvALTOPREVlovastatinTABLET, EXTENDED RELEASE;ORAL021316-002Jun 26, 2002RXYesNo► Subscribe► Subscribe► SubscribeMETHOD OF DECREASING THE PRODUCTION OF A-BETA USING A COMPOSITION WHICH DECREASES BLOOD CHOLESTEROL IN PATIENTS AT RISK OF OR EXHIBITING SYMPTOMS OF ALZHEIMER'S DISEASE
Covis Pharma BvALTOPREVlovastatinTABLET, EXTENDED RELEASE;ORAL021316-003Jun 26, 2002RXYesNo► Subscribe► Subscribe► SubscribeMETHOD OF DECREASING THE PRODUCTION OF A-BETA USING A COMPOSITION WHICH DECREASES BLOOD CHOLESTEROL IN PATIENTS AT RISK OF OR EXHIBITING SYMPTOMS OF ALZHEIMER'S DISEASE
Covis Pharma BvALTOPREVlovastatinTABLET, EXTENDED RELEASE;ORAL021316-004Jun 26, 2002RXYesYes► Subscribe► Subscribe► SubscribeMETHOD OF DECREASING THE PRODUCTION OF A-BETA USING A COMPOSITION WHICH DECREASES BLOOD CHOLESTEROL IN PATIENTS AT RISK OF OR EXHIBITING SYMPTOMS OF ALZHEIMER'S DISEASE
This preview shows a limited data set
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.

« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving leading biopharmaceutical companies globally:

Colorcon
Merck
Chinese Patent Office
Federal Trade Commission
Express Scripts
Johnson and Johnson
Farmers Insurance
QuintilesIMS
Healthtrust
Argus Health

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot